• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Mild Cognitive Impairment Companies

    ID: MRFR/HC/9432-CR
    151 Pages
    Rahul Gotadki
    May 2024

    Mild Cognitive Impairment (MCI) is a condition characterized by noticeable cognitive decline that is greater than expected for an individual's age but not severe enough to interfere significantly with daily life. Various pharmaceutical and healthcare companies may be involved in research, drug development, and initiatives related to cognitive health, including MCI. 

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Mild Cognitive Impairment Market Research Report - Global Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Mild Cognitive Impairment Market

    Mild Cognitive Impairment Key Companies

     

    Latest Mild Cognitive Impairment Companies Update


    Eli Lilly receives Fast Track designation for donanemab in MCI: In December 2023, Lilly received FDA Fast Track designation for donanemab, an anti-amyloid antibody, for the treatment of early Alzheimer's disease and MCI due to Alzheimer's pathology. This signifies a potential acceleration in the drug's approval process.


    Biogen announces plans for Phase 3 trials of aducanumab in MCI Despite aducanumab's controversial approval for Alzheimer's disease, Biogen is planning Phase 3 trials to assess its efficacy in MCI prevention. This could potentially expand the drug's reach earlier in the disease progression.


    TauRx Therapeutics reports positive Phase 2a results for TauRX301 in progressive supranuclear palsy (PSP) While not directly targeting MCI, TauRx Therapeutics' positive Phase 2a results for TauRX301 offer hope for developing similar Tau-targeting therapies for MCI and other neurodegenerative diseases.



     

    List of Mild Cognitive Impairment Key Companies in The Market



    • Pfizer Inc. (US)

    • Hoffman La Roche Ltd (Switzerland)

    • Novartis AG (Switzerland)

    • Accord UK Ltd (UK)

    • Reddy’s laboratories Ltd (India)

    • Hikma Pharmaceuticals PLC (UK)

    • Sun Pharmaceuticals ltd (India)

    • Johnson & Johnson Services, Inc. (US)

    • Teva Pharmaceutical Industries Ltd., (Israel)

    • Takeda Pharmaceutical Company Limited (US)